European Companies Search Engine
Wordmark: “Senzer“ Euipotm3 Jan 2026 European Union Intellectual Property Office (Trade Marks)
History
Text
Trade mark
| Type | Word |
| Name | Senzer |
| Filing number | 013791124 |
| Trade mark status | REGISTRATION_EXPIRED |
| Nice Classification |
5: Pharmaceutical preparations for the treatment of pain, asthma, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea and vomiting, stroke, cancer, drug dependence, drug addiction, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, mental illness, and other intestinal, neurological and cardiovascular disorders; substances adapted for medical use for the treatment of pain, asthma, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea and vomiting, stroke, cancer, drug dependence, drug addiction, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, other intestinal, neurological and cardiovascular disorders; vaccines for the treatment of pain, asthma, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea and vomiting, stroke, cancer, drug dependence, drug addiction, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, mental illness, and intestinal and cardiovascular disorders; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for the treatment of pain, asthma, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea and vomiting, stroke, cancer, drug dependence, drug addiction, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, mental illness, and other intestinal, neurological and cardiovascular disorders; drug delivery agents in the form of powders, capsules, inhalers, that facilitate the delivery of pharmaceutical preparations; none of the aforesaid being for or in relation to preparations for the treatment of liver diseases. 10: Inhalers; filters for inhalers; inhalers for medical use; inhalers for therapeutic use; drug delivery systems; medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems; microneedle arrays for delivering medications; hypodermic syringes for injections for medical purposes; all of the aforesaid for use in delivering pharmaceutical preparations for the treatment of pain, asthma, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea and vomiting, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, mental illness, and intestinal, neurological and cardiovascular disorders; none of the aforesaid being for or in relation to preparations for the treatment of liver diseases. |
| Filing date | 03/03/2015 |
| Registration date | 28/06/2017 |
| Expiry date | 03/03/2025 |
| Owners |
Senzer Limited Senzer Limited, 2 Angel Square London London, City of EC1V1NY United Kingdom |
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Senzer Ltd., Salisbury.